Advertisement
Screener

PHATHOM PHARMACEUTICALS, INC. (PHAT) ROA

PHATHOM PHARMACEUTICALS, INC. (PHAT) ROA

  • 2026-06-30: ROA -30.29%.
  • 2026-03-31: ROA -51.55%.
  • 2025-12-31: ROA -85.37%.
  • 2025-09-30: ROA -114.26%.

Complete source-backed roa history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-30.29%
2026-03-31-51.55%
2025-12-31-85.37%
2025-09-30-114.26%
2025-06-30-131.95%
2025-03-31-117.53%
2024-12-31-88.37%
2024-09-30-87.70%
2024-06-30-93.03%
2024-03-31-69.18%
2023-12-31-48.71%
2023-09-30-74.72%
2023-06-30-69.77%
2023-03-31-135.32%
2022-12-31-119.97%
2022-09-30-88.40%
2022-06-30-76.85%
2022-03-31-100.44%
2021-12-31-75.96%
2021-09-30-70.84%
2021-06-30-74.20%
2021-03-31-58.36%
2020-12-31-43.74%
2020-09-30-75.08%
2020-06-30-82.15%
2020-03-31-103.83%
2019-12-31-99.20%
2019-09-30-197.74%
2018-12-31-142.79%

Annual ROA

DateROA
2025-12-31-85.37%
2024-12-31-88.37%
2023-12-31-48.71%
2022-12-31-119.97%
2021-12-31-75.96%
2020-12-31-43.74%
2019-12-31-99.20%
2018-12-31-142.79%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Altimmune, Inc. (ALT)United States$0.593B-6.43
Monopar Therapeutics (MNPR)United States$0.598B-34.82
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Evolus, Inc. (EOLS)United States$0.519B-13.32
Neurogene Inc. (NGNE)$0.625B-4.46